B13-peptides-antimicrobial-and-neurotrophic-activity
Aurélie Tasiemski, Michel Salzet
US 8,173,768 B2
https://patents.google.com/patent/US8173768B2/en
Abstract
A method for preventing the onset of, and for treating, a neurodegenerative disease by administering an effective amount of a peptide that is at once antimicrobial and neurotrophic. The patent brings the two activities together in a single molecule, extending the laboratory’s invertebrate antimicrobial peptide work towards neuroprotection.
Patent family
| Publication number | Office | Kind | Published |
|---|---|---|---|
| US 8,173,768 B2 | United States | Granted | 2012-05-08 |
- Priority date — 13 July 2009
- Filing date — 13 July 2009
- Status — Granted
- Applicants — CNRS, Université des Sciences et Technologies de Lille
- Research axis — Invertebrate antimicrobial peptides
Context
The hinge between the antimicrobial peptide line (EP 2 516 453, EP 2 488 216) and neurobiology: one molecule, two activities. It is the only granted patent of that group of three.
Abstract as published
A method for preventing a break out of a neurodegenerative disease in an individual and for treating an individual suffering from a neurodegenerative disease comprising the administration of an effective amount of an antimicrobial and neurotrophic peptide.